| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5645124 | Annals of Allergy, Asthma & Immunology | 2017 | 9 Pages |
Abstract
During the last 25 years more than several hundred allergen sequences were determined, which led to a production of recombinant allergens that mimic biochemically and immunologically their natural counterparts. Especially in Europe, recombinant allergens are increasingly replacing allergen extracts in diagnosis of allergy. Despite many challenges, such as high cost of clinical trials and regulative issues, allergy vaccines based on recombinant allergens and peptides are being developed and will likely soon be available on the market.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Mirela PhD, Viktoriya MD, PhD, Rudolf MD,